Biomarkers 2014 in CNS Drug Discovery and Development: From Discovery to Clinical Diagnostics

  • Conference Call
  • Select Bio­sciences Ltd., work­ing together with Andreas Jeromin are pleased to announce their joint col­lab­o­ra­tion: Bio­mark­ers in CNS Drug Dis­cov­ery and Devel­op­ment: From Dis­cov­ery to Clin­i­cal Diag­nos­tics. The event will take place in Cam­bridge, United King­dom on July 7 – 8, 2014.

    This meet­ing will high­light cur­rent advances in the use of bio­mark­ers in the con­text of CNS drug dis­cov­ery and devel­op­ment and high­light strate­gies for their trans­la­tion from dis­cov­ery tolls to clin­i­cal diag­nos­tics. This is embed­ded into the dis­cus­sion of inno­vate tech­nolo­gies for bio­marker devel­op­ment, their non-​clinical use, clin­i­cal devel­op­ment and reg­u­la­tory strate­gies and serve as a unique forum for net­work­ing, crit­i­cal assess­ment based on pre­sented case stud­ies and panel dis­cus­sions. It will bring together a group of inter­na­tional experts across acad­emy and indus­try across a spec­trum of CNS dis­or­ders, rang­ing from neu­rode­gen­er­a­tive, neu­ropsy­chi­atric, neu­rode­vel­op­men­tal to neu­ro­log­i­cal disorders.

    Keynote Speakers

    Con­firmed Speak­ers to date

    • John Allinson – Head of Bio­marker Strat­egy, LGC
    • Sabine Bahn – Direc­tor, Uni­ver­sity of Cambridge
    • Lucie Bruijn – Chief Sci­en­tist, The ALS Association
    • Paul Edi­son – Clin­i­cal Senior Lec­turer, Imperial
    • Chris­t­ian Foerch – Head of the Cere­brovas­cu­lar Research Group at the Depart­ment of Neu­rol­ogy, Goeth University
    • Kim Hen­rik­sen – Head of Mus­cu­loskele­tal Dis­eases, Nordic Bio­science, Bio­mark­ers and Research
    • Andrea Malaspina – Clin­i­cal Senior Lec­turer, Queen Mary Uni­ver­sity of London
    • Katrin Mar­cus – Ruhr-​University Bochum
    • Brit Mol­len­hauer – Head of Clin­i­cal Research, Paracelsus-​Elena-​Klinik
    • Alan Palmer – CSO, MS Therapeutics
    • Emilio Pich – Head of Clin­i­cal Imag­ing, F. Hoffmann-​La Roche
    • Ian Pike – COO, Pro­teome Sci­ences PLC
    • Jill Richard­son – Direc­tor, Exter­nal Alliances and Devel­op­ment, R&D China, GlaxoSmithKline
    • Marinella San­dros – Assis­tant Pro­fes­sor of Nanoscience, Uni­ver­sity of North Car­olina at Greensboro
    • Rachael Scahill – Senior Researcher, UCL
    • Mar­tin Turner – Con­sul­tant Neu­rol­o­gist, Oxford MND Cen­tre Co-​Director, Oxford University
    • Claude Wis­chik – Exec­u­tive Chair­man & Co Founder, TauRx Ther­a­peu­tics Ltd

    Agenda Topics

    • Bio­mark­ers In Clin­i­cal Devel­op­ment and Emerg­ing Strate­gies for Patient Enrichment/​Stratification as Com­pan­ion Diagnostics
    • Con­sid­er­a­tions for Reim­burse­ment in the Post-​approval Process
    • Dif­fer­ent “Busi­ness Mod­els” in CNS Drug Discovery/​Development
    • Imple­men­ta­tion of Trans­la­tional Biomarkers
    • Novel Approaches for Bio­marker Qual­i­fi­ca­tion and the Devel­op­ment of Clin­i­cal Diagnostics
    • Reg­u­la­tory Approaches for Bio­marker Qual­i­fi­ca­tion and the Devel­op­ment of Clin­i­cal Diagnostics
    • Stan­dard­iza­tion of Ana­lyt­i­cal Approaches
    • Tech­no­log­i­cal Approaches for Bio­marker Dis­cov­ery and Devel­op­ment Across Modalities

    Call for Posters

    You can also present your research on a poster while attend­ing the meet­ing. Sub­mit an abstract for con­sid­er­a­tion now!

    starting: ending: 09.07.2014 Location: , Category:


    Conference START 09.07.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Huntingdon Road Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.